talactoferrin

Related by string. Talactoferrin * * talactoferrin arm . oral talactoferrin . developing oral talactoferrin *

Related by context. All words. (Click for frequent words.) 72 forodesine 71 elotuzumab 71 ELACYT 71 Allovectin 7 R 70 alvespimycin 70 KIACTA ™ 70 MAGE A3 ASCI 70 CR# vcMMAE 70 INCB# [001] 70 trastuzumab DM1 T DM1 70 #D#C# 70 HGS ETR1 69 MOZOBIL 69 pralatrexate 69 custirsen 69 oral ridaforolimus 69 Allovectin 7 69 CoFactor 69 PXD# 69 Aurexis 68 Bezielle 68 RGB # 68 neratinib 68 ZYBRESTAT 68 Civacir 68 CINTREDEKIN BESUDOTOX 68 Panzem R 68 TOCOSOL Paclitaxel 68 Insegia 68 lomitapide 68 huC# DM4 68 Fibrillex TM 68 vidofludimus 68 oral prodrug 68 GALNS 67 Troxatyl 67 ruxolitinib 67 HuMax EGFr 67 ganetespib 67 BAY #-# 67 Virulizin R 67 ularitide 67 glufosfamide 67 TELINTRA 67 LymphoStat B 67 Archexin 67 bafetinib 67 Azedra 67 valopicitabine 67 Tarceva TM 67 HuLuc# 67 L BLP# 67 DPX Survivac 67 YONDELIS 67 Phase IIb clinical trials 67 ponatinib 67 TYZEKA 67 Marqibo 67 docetaxel Taxotere R 67 ASONEP 67 CRMD# 67 faropenem 67 refractory gout 67 deforolimus 67 eltrombopag 67 IMA# 67 BCX# 67 Zerenex 67 Ceflatonin 67 Azixa 67 PEG Interferon lambda 67 eniluracil 66 ASA# 66 darapladib 66 HGS ETR2 66 amrubicin 66 HspE7 66 EndoTAG TM -1 66 axitinib 66 Exelixis compounds 66 Nexavar ® 66 MAXY alpha 66 dacetuzumab 66 ofatumumab 66 registrational 66 Genasense ® 66 obatoclax 66 BrachySil TM 66 romidepsin 66 mertansine 66 SAR# [004] 66 Virulizin ® 66 IRX 2 66 Phenoptin 66 Proxinium TM 66 otelixizumab 66 ALN RSV# 66 OncoVEX GM CSF 66 entinostat 66 RhuDex ® 66 pradefovir 66 JAK1 66 motesanib 66 SinuNase TM 66 maribavir 66 zanolimumab 66 CTAP# Capsules 66 Phase 2a trial 66 PEG SN# 66 PNP inhibitor 66 sorafenib tablets 66 PI3K/Akt pathway inhibitor 66 satraplatin 66 vosaroxin 66 oxymorphone ER 66 Allovectin 7 ® 66 dexanabinol 66 Bicifadine 66 lintuzumab 66 phase IIb clinical 66 tanespimycin 66 PDE4 inhibitor 65 TKM ApoB 65 HER2 positive metastatic breast 65 PRT# 65 FOLOTYN ® 65 EFAPROXYN 65 oral picoplatin 65 relapsed multiple myeloma 65 enzastaurin 65 FOLOTYN 65 MGCD# [001] 65 celgosivir 65 Panzem R NCD 65 UVIDEM 65 successfully commercialize Iluvien 65 CytoFab 65 Abiraterone acetate 65 Phase IIb trials 65 vernakalant oral 65 picoplatin 65 AzaSite Plus 65 AEG# 65 Vicinium TM 65 PLK1 SNALP 65 Diamyd ® 65 bardoxolone 65 IL# PE#QQR 65 orally administered inhibitor 65 mifamurtide 65 phase IIa clinical 65 R sorafenib tablets 65 Cloretazine ® 65 investigational humanized monoclonal antibody 65 Tavocept 65 velafermin 65 voreloxin 65 Restanza 65 Veronate 65 EndoTAG TM 65 albinterferon alfa 2b 65 AQ4N 65 BENLYSTA ® 65 MAXY G# 65 RIGScan CR 65 ThermoDox R 65 L MTP PE 65 cilengitide 65 OvaRex ® MAb 65 alvimopan 65 ELND# 65 Phase Ib study 65 isoform selective 65 tezampanel 65 Exherin TM 65 torezolid phosphate 65 NEUMUNE 65 SNT MC# 65 reslizumab 65 acyclovir Lauriad R 65 pertuzumab 65 Xanafide 65 Cethrin 65 Personalized Immunotherapy 65 NP2 Enkephalin 65 dirucotide 65 zalutumumab 65 liprotamase 65 GRN# 65 XL# XL# XL# XL# 65 Ophena TM 64 HCV protease inhibitor 64 HuMax CD4 64 Icatibant 64 OMAPRO 64 Ketotransdel 64 lintuzumab SGN 64 LE DT 64 UPLYSO 64 omega interferon 64 JAK inhibitor 64 forodesine hydrochloride 64 IAP inhibitors 64 metastatic castration resistant 64 LymphoStat B TM 64 antibody MAb 64 Traficet EN 64 ONCONASE 64 TORISEL 64 telaprevir VX 64 Surfaxin LS 64 registrational trial 64 Sulonex TM 64 Asentar 64 Phase #/#a trial 64 anidulafungin 64 PEG PAL 64 Cethromycin 64 OXi# 64 SinuNase 64 heavily pretreated 64 CINQUIL 64 thetreatment 64 CBLC# 64 Phase IIIb clinical 64 Allovectin 7 r 64 adecatumumab 64 Anthim 64 HGS# 64 tremelimumab 64 Aflibercept 64 BLA filing 64 EOquin TM 64 Viramidine 64 AP# [003] 64 Cimzia TM 64 oral methylnaltrexone 64 tezampanel NGX# 64 velafermin belinostat 64 lumiliximab 64 CCR9 antagonist 64 PSN# [002] 64 HCV protease inhibitors 64 Behcet uveitis 64 JAK2 inhibitor 64 Shigamabs ® 64 rindopepimut 64 Omigard 64 novel VDA molecule 64 rALLy trial 64 thymalfasin 64 teduglutide 64 LibiGel ® 64 CIMZIA ™ 64 TELCYTA 64 tamibarotene 64 perifosine 64 CIMZIA TM 64 tramiprosate Alzhemed TM 64 ACTEMRA TM 64 phase IIb trial 64 CA4P 64 hematological cancers 64 severe hypercholesterolemia 64 Evoltra ® 64 ALN PCS 64 ZOLINZA 64 XmAb# 64 HCD# [002] 64 lesinurad 64 ATL# [001] 64 LEUKINE 64 liposomal formulation 64 MAA submission 64 catheter occlusion 64 methylnaltrexone 64 dose cohort 64 investigational monoclonal antibody 64 R#/MEM # 64 Vitaxin 64 iclaprim 64 Zenvia ™ 64 Entereg R 64 initiate Phase 1b 64 riociguat 64 XL# XL# 64 ospemifene 64 squalamine 64 OMNARIS HFA 64 BEMA Buprenorphine 64 GVAX ® 64 ulimorelin 63 CDP# 63 systemically administered 63 ISIS # 63 Belinostat 63 KNS # 63 Perifosine 63 Voraxaze ™ 63 oral talactoferrin 63 MyVax ® 63 Phase #b/#a clinical 63 Nexavar sorafenib 63 Octreolin 63 Serdaxin 63 Nanobody 63 Phase 2b clinical 63 incyclinide 63 Amrubicin 63 Mipomersen 63 TRISENOX 63 ProSavin 63 novel histone deacetylase 63 ocrelizumab 63 Canvaxin 63 PRTX 63 adecatumumab MT# 63 Cloretazine R VNP#M 63 sodium thiosulfate STS 63 CYT# potent vascular disrupting 63 Panzem 63 oral salmon calcitonin 63 MGCD# [002] 63 daclizumab 63 Phase IIa trials 63 EOquin 63 urocortin 2 63 Targretin 63 cobiprostone 63 Lucanix R 63 receptor tyrosine kinase inhibitor 63 cystinosis patients 63 docetaxel Taxotere ® 63 tesetaxel 63 WILEX 63 T DM1 63 nalbuphine ER 63 PHX# 63 recombinant biopharmaceutical 63 Cetrorelix 63 Altastaph 63 Urocidin 63 sunitinib malate 63 sapacitabine 63 ARIKACE ™ 63 Aplidin 63 ADVEXIN 63 relapsed refractory multiple myeloma 63 Zingo TM 63 PROMACTA 63 acetonide FA 63 LBH# 63 MT# MEDI 63 CORLUX CORT # 63 rALLy clinical trial 63 PREOS 63 rNAPc2 63 MyVax R 63 Evoltra TM 63 metaglidasen 63 CCX# 63 NVA# 63 ixabepilone 63 MYDICAR ® 63 TBC# 63 MYDICAR 63 HQK 63 Chemophase 63 Solazed TM 63 Golimumab 63 elagolix 63 castrate resistant prostate cancer 63 atacicept 63 PS# [001] 63 cangrelor 63 tafamidis 63 Fodosine 63 oral taxane 63 Hedgehog antagonist 63 huN# DM1 63 trastuzumab DM1 63 Cerashield 63 diabetic neuropathic pain 63 CD# CEA 63 sorafenib Nexavar 63 Mepact 63 PDX pralatrexate 63 Phase Ib II 63 MKC# MT 63 Pazopanib 63 Protexia R 63 ACZ# 63 Factor VIIa 63 oral antiviral 63 posaconazole 63 BioNumerik 63 metastatic CRC 63 anticancer compound 63 Bronchitol 63 TACI Ig 63 Azedra ™ 63 radiation sensitizer 63 drug ISA# 63 cintredekin besudotox 63 MORAb 63 Nicole Onetto MD 63 investigational therapies 63 HepeX B 63 HuMax CD# 63 metastatic RCC 63 FavId 63 Aryplase 63 leading oral taxane 63 BLA submission 63 HEPLISAV 63 vemurafenib 63 Plicera 63 oral FTY# 63 Aerosurf 63 BrachySil 63 ZADAXIN ® 63 IMGN# 63 mapatumumab 63 EnzymeRx 63 lucinactant 63 Phase IIa trial 63 regorafenib 63 histone deacetylase HDAC inhibitor 63 Excellarate TM 63 lenalidomide Revlimid R 63 IND submission 63 palifosfamide 63 Stimuvax R 63 relapsed leukemia 63 Relivar 63 canakinumab 63 Tyrima 63 interferon gamma 1b 63 investigational compound 63 LY# [003] 63 Orathecin 63 TLK# 63 cancer immunotherapies 63 P#X# antagonist 63 Delcath PHP System 63 pexiganan 63 dalbavancin 63 nonclinical studies 63 MDV# 63 MEK inhibitors 63 including eniluracil ADH 63 Phase 2a clinical trials 63 blinatumomab 63 CytoFabTM 63 PSMA ADC 63 Exelixis XL# 63 MEK inhibitor RDEA# 62 NEBIDO 62 BRAF V# mutation 62 pediatric acute lymphoblastic 62 bevacizumab Avastin ® 62 phase IIb 62 Dextofisopam 62 Symadex 62 PROSTVAC TM 62 Chrysalin 62 CEQ# 62 lorvotuzumab mertansine 62 Rhucin ® 62 Hsp# inhibition 62 BiTE antibody 62 aflibercept 62 denufosol 62 Solazed 62 OncoGel 62 bazedoxifene 62 prostone 62 LymphoStat B belimumab 62 Epothilone D 62 lapatinib Tykerb 62 Valortim 62 standard chemotherapy regimen 62 LentiVector technology 62 microplasmin 62 Reverset 62 DU #b 62 Triolex 62 docetaxel Taxotere 62 Clolar ® 62 ongoing Phase IIIb 62 OHR/AVR# 62 Sebivo 62 PGL# 62 metastatic hormone refractory 62 metastatic castrate resistant 62 PrevOnco ™ 62 ancrod 62 Tasimelteon 62 immunotherapeutic vaccine 62 Azedra TM 62 Marqibo TM 62 Pruvel 62 Romidepsin 62 Viprinex 62 AAG geldanamycin analog 62 Aurora kinase inhibitor 62 rALLy 62 Prestara 62 INCB# [002] 62 KRN# 62 JAK inhibitors 62 ATL/TV# 62 IMiDs 62 apaziquone 62 NV1FGF 62 PRECISE trial 62 Actilon 62 budesonide foam 62 ORENCIA R 62 SARMs 62 refractory multiple myeloma 62 Imprime PGG 62 refractory chronic lymphocytic 62 RNAi therapeutic 62 pomalidomide 62 DXL# 62 ALN VSP 62 Desmoteplase 62 voclosporin 62 Alocrest 62 Junovan 62 Annamycin 62 TRO# 62 iroxanadine 62 TYSABRI natalizumab 62 OncoVEX 62 SUTENT 62 virus HCV infection 62 abiraterone acetate 62 GED aPC 62 Genz # 62 mocetinostat MGCD# 62 dimebon 62 OvaRex R 62 pegloticase 62 docetaxel chemotherapy 62 investigational compounds 62 AERx iDMS 62 nitazoxanide 62 NGX# 62 QAB# 62 volociximab 62 Adentri 62 Dacogen injection 62 class mGluR5 inhibitor 62 FORTIS M trial 62 RSD# oral 62 telomerase therapeutic 62 oral anticancer 62 anticancer therapy 62 phase 2a 62 EP #R 62 casopitant 62 cutaneous T cell 62 systemic fungal infections 62 Cloretazine 62 ZADAXIN 62 Satraplatin 62 ALN TTR 62 INC# 62 TroVax ® 62 tiapamil 62 ApoB SNALP 62 CD3 monoclonal antibody 62 GLP toxicology studies 62 Cleviprex TM clevidipine 62 anticoagulant reversing agent 62 virus HCV protease inhibitor 62 refractory PTCL 62 INTEGRILIN 62 Nuvion 62 hoFH 62 Uvidem 62 Phase IIa clinical trials 62 SILENOR TM 62 AVE# 62 Vandetanib 62 Zolinza 62 NEUVENGE 62 ONCONASE R 62 cetuximab Erbitux 62 Ceflatonin R 62 induced macular edema 62 mRCC 62 BiovaxID TM 62 vaccines oncolytic virus 62 Xinlay 62 refractory metastatic 62 pafuramidine 62 SinuNase ™ 62 Leukine 62 TREANDA 62 oncology indications 62 gemcitabine chemotherapy 62 targeted radiotherapeutic 62 RLY# 62 pseudobulbar affect PBA 62 Zalbin 62 refractory AML 62 Stedivaze 62 Phase Ib clinical trials 62 NovaBay Aganocide compounds 62 Cellegesic 62 FermaVir 62 postoperative ileus POI 62 teriflunomide 62 daptomycin 62 XL# [003] 62 TRAIL receptor antibodies 62 ridaforolimus 62 Arikace 62 Daclizumab 62 XYOTAX 62 SEPET TM 62 opioid induced bowel dysfunction 62 phase IIb study 62 Tamibarotene 62 Poly ICLC 62 XL# XL# XL# 62 trastuzumab Herceptin R 62 maximally tolerated dose 62 CRLX# 62 Onconase 62 Hyphanox 61 Proellex TM 61 please visit www.advaxis.com 61 Omacetaxine 61 RNAi therapeutic targeting PCSK9 61 rilonacept 61 Zerenex ™ 61 pain palliation 61 REOLYSIN ® 61 TRIOLEX 61 registrational studies 61 TransVax ™ 61 Anturol TM 61 OPAXIO 61 Dapagliflozin 61 non nucleoside HCV 61 MEK inhibitor 61 PEGylated interferon beta 1a 61 ARIKACE 61 MPS IVA 61 eritoran 61 SILENOR 61 Acute Radiation Syndrome ARS 61 TMC# [002] 61 ALN TTR# 61 ZFP Therapeutic 61 Hsp# inhibitor 61 SCIB1 61 StemEx R 61 Jevtana 61 AMPK activators 61 IV APAP 61 Triapine R 61 Vernakalant 61 Onrigin 61 Xerecept 61 SUCCEED trial 61 Cotara 61 CIMZIA TM certolizumab pegol 61 ProLindac 61 Lupuzor 61 Onalta 61 dextromethorphan quinidine 61 IMC #B 61 AEZS 61 prostate cancer CRPC 61 Phase IIb clinical 61 EVIZON 61 Ramoplanin 61 bosutinib 61 IMC A# 61 LEP ETU 61 Seliciclib 61 Genasense oblimersen sodium Injection 61 Synavive 61 Syncria 61 BRIM2 61 Vilazodone 61 Benlysta belimumab 61 oncolytic virus therapies 61 OZURDEX ® 61 AZILECT R 61 orally bioavailable 61 myelofibrosis 61 Neuradiab 61 IDX# 61 TOLAMBA 61 Amigal 61 MGN# 61 Phase Ib 61 elacytarabine 61 Pirfenidone 61 HoFH 61 vilazodone 61 talabostat 61 Zemiva TM 61 Talabostat 61 PROVENGE 61 Menerba 61 EVIZON TM squalamine lactate 61 therapeutic monoclonal antibody 61 evaluating tivozanib 61 hematological malignancies 61 phase Ib 61 CD# antibody [001] 61 drug pipeline TAFA# 61 octreotide implant 61 esophageal candidiasis 61 Canvaxin TM 61 delivers fluocinolone acetonide FA 61 Telintra 61 Trofex 61 IRESSA 61 Aviptadil 61 DCVax R 61 bicifadine 61 XL# anticancer compounds 61 Targretin capsules 61 vaginally administered lidocaine 61 ELIQUIS 61 refractory Hodgkin lymphoma 61 BEMA TM Fentanyl 61 PANVAC VF 61 VEGFR2 inhibitor 61 Onbrez Breezhaler 61 AIMM trial 61 Tarceva erlotinib 61 compound INCB# 61 MAP# 61 eculizumab 61 PROVENGE sipuleucel T 61 Gemzar ® 61 GLPG# 61 Phase 1b 61 castration resistant prostate cancer 61 GAP #B# 61 ENRICH trial 61 Elagolix 61 nucleoside analog 61 AEGR 61 Zoraxel 61 personalized cellular immunotherapy 61 Phase 2a 61 Xcytrin R 61 Adnectin 61 tivozanib 61 crofelemer 61 Tanespimycin 61 Anturol 61 midstage studies 61 Actemra tocilizumab 61 Tesetaxel 61 inflammatory autoimmune diseases 61 elvucitabine 61 JNJ Q2 61 cannabinor 61 subsidiaries visit http:/www.apricusbio.com 61 ACTEMRA 61 clevidipine 61 BENLYSTA 61 lymphoid malignancies 61 liposomal ciprofloxacin 61 multi kinase inhibitor 61 RDEA# 61 MYCAMINE 61 Afatinib 61 selective androgen receptor modulator 61 SonoLysis 61 dextofisopam 61 intranasal delivery 61 vismodegib 61 Hepatocellular Carcinoma HCC 61 Nasulin 61 glucokinase activator 61 Diamyd R 61 severe gastroparesis 61 AMEVIVE 61 GVAX R 61 metastatic sarcomas 61 apricitabine ATC 61 modified glutathione analog 61 oral PTH 61 romazarit 61 belinostat 61 danoprevir 61 erlotinib Tarceva ® 61 darinaparsin 61 Locteron 61 REMICADE ® 61 RSR# 61 radezolid 61 Lenocta 61 QNEXA 61 omecamtiv mecarbil 61 Soliris TM eculizumab 61 Æterna Zentaris 61 ACAPODENE 61 Prodarsan ® 61 ambrisentan 61 MEK Inhibitor 61 IoGen 61 NXL# 61 anti leukemic 61 Fludara ® 61 GVAX 61 DACH platinum 61 Onalta ™ 61 Atiprimod 61 investigational pan BCR 61 FTY# 61 nab paclitaxel 61 TKM PLK1 61 StemEx 61 panitumumab 61 HGS ETR1 mapatumumab 61 MVA BN R 61 Eligen ® Technology 61 T Pred 61 anti angiogenic agents 61 QLT# 61 Alpharadin 61 ILUVIEN ® 61 ICA # 61 subcutaneous formulation 61 epigenetic therapies 61 anthracycline taxane 61 olaparib 61 SUPPRELIN R LA 61 MyVax 61 Phase III HEAT 61 Zemplar Capsules 61 Quinamed 61 topical anti infective 61 Sym# 61 farletuzumab 61 anti EGFR antibody 61 baminercept 61 BiovaxID 61 Viprinex TM 61 optimal dosing regimens 61 Ixempra 61 INT# [002] 61 Pivotal Phase III 61 RNAi therapeutic targeting 61 ONTAK 61 molecular imaging radiopharmaceutical 61 PREOS R 61 Hsp# inhibitors 61 Reclast Aclasta 61 YONDELIS R 61 Phase 2a clinical 61 forodesine HCl 61 BZL# 61 GGF2 61 metastatic renal cell 61 Trofex TM 61 Cintredekin Besudotox 61 Carfilzomib 61 Peginterferon alfa 2b 60 metastatic HRPC 60 omacetaxine mepesuccinate 60 Intarcia 60 DexaSite 60 Bortezomib 60 betrixaban 60 PRX # 60 NKTR 60 Targeted Chemotherapy 60 Azilect ® 60 Oracea TM 60 non nucleoside inhibitor 60 oral deforolimus 60 IMiDs ® 60 phase IIa 60 EndoTAGTM 1 60 Velcade bortezomib 60 Zavesca R 60 synthetic retinoid 60 Phase 2b study 60 Microplasmin 60 telbivudine 60 MAXY VII 60 Phase III clinical trials 60 RhuDex TM 60 Amplimexon 60 Liprostin 60 NATRECOR R 60 RhuDex R 60 Cimzia R 60 GSK# [001] 60 Dalbavancin 60 GRNVAC1 60 Phase 1b trial 60 Cx# [002] 60 Kosan dependence 60 Mycograb 60 Genasense ® oblimersen 60 iniparib 60 vascular disrupting agent 60 Rhucin ® recombinant 60 histone deacetylase inhibitor 60 sapropterin dihydrochloride Tablets 60 Xyfid TM 60 PEGylated Fab fragment 60 Tekamlo 60 Campath ® 60 CRx 60 Phenserine 60 pemetrexed Alimta 60 Generx 60 Zybrestat 60 HuMax TAC 60 relapsed SCLC 60 eprotirome 60 Certican 60 formerly LymphoStat B 60 goserelin 60 MNTX 60 BRAF inhibitor 60 Aptivus ® 60 DDP# 60 octreotide acetate 60 injectable formulation 60 ATL# [002] 60 Copegus ribavirin 60 SEBIVO 60 Zavesca r 60 Myocet 60 chemopreventive agent 60 cutaneous T 60 oral nucleoside analogue 60 senicapoc 60 KIACTA TM 60 Symphony tCGM 60 CYC# 60 chronic HCV infection 60 DOS# 60 Glufosfamide 60 pan HDAC inhibitor 60 mitogen activated ERK kinase 60 TYGACIL 60 apremilast 60 Gleevec Glivec 60 DAVANAT R 60 luliconazole 60 refractory cutaneous T 60 cytokine refractory 60 VQD 60 Androxal ® 60 Aurora kinase 60 Cimzia ® 60 Neo Kidney Augment 60 investigational antiplatelet agent 60 Protexia ® 60 recurrent NSCLC 60 Clonicel 60 Numax 60 Unit Dose Budesonide 60 fostamatinib 60 Clavis Pharma 60 valopicitabine NM# 60 rhC1INH 60 recurrent glioblastoma multiforme 60 PROCHYMAL 60 ostarine 60 Rasilez Tekturna 60 Dyloject TM 60 PrevOnco 60 fidaxomicin 60 Phase IIB 60 Catena ® 60 clinical trials 60 JOULFERON 60 Aclidinium 60 non metastatic osteosarcoma 60 TRISENOX ® 60 Clevudine 60 Generx TM 60 Intravenous CP 60 PREZISTA r 60 Actimmune ® 60 G#DT 60 favorable pharmacokinetic profile 60 INCB# [003] 60 candidate XP# 60 eosinophilic asthma

Back to home page